UNICA IRIS Institutional Research Information System

DEMELIA, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 108.674
NA - Nord America 6.115
AS - Asia 2.708
SA - Sud America 359
Continente sconosciuto - Info sul continente non disponibili 149
AF - Africa 57
OC - Oceania 2
Totale 118.064
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 104.998
US - Stati Uniti d'America 6.031
NL - Olanda 1.876
CN - Cina 1.090
SG - Singapore 972
UA - Ucraina 546
DE - Germania 330
SE - Svezia 300
BR - Brasile 270
FI - Finlandia 225
VN - Vietnam 203
GB - Regno Unito 167
FR - Francia 133
HK - Hong Kong 90
BD - Bangladesh 75
KR - Corea 51
CA - Canada 43
IN - India 39
AR - Argentina 34
RU - Federazione Russa 33
ID - Indonesia 26
JP - Giappone 23
MX - Messico 21
PK - Pakistan 19
IQ - Iraq 18
EC - Ecuador 15
TR - Turchia 15
UZ - Uzbekistan 14
BE - Belgio 13
MA - Marocco 13
VE - Venezuela 12
PH - Filippine 11
KE - Kenya 10
PL - Polonia 10
ZA - Sudafrica 10
CO - Colombia 9
SA - Arabia Saudita 9
AT - Austria 8
ES - Italia 7
IL - Israele 7
MY - Malesia 7
CR - Costa Rica 5
EG - Egitto 5
JO - Giordania 5
OM - Oman 5
PE - Perù 5
PY - Paraguay 5
TN - Tunisia 5
DK - Danimarca 4
LB - Libano 4
MD - Moldavia 4
MU - Mauritius 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
EU - Europa 3
HN - Honduras 3
IE - Irlanda 3
IR - Iran 3
JM - Giamaica 3
NG - Nigeria 3
NP - Nepal 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AU - Australia 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
SN - Senegal 2
TH - Thailandia 2
BB - Barbados 1
BG - Bulgaria 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MQ - Martinica 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SD - Sudan 1
SI - Slovenia 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 117.919
Salva come PNG Salva come JPEG
Città #
Cagliari 103.540
Amsterdam 1.869
Uta 1.136
Fairfield 549
Singapore 482
Ashburn 427
Woodbridge 427
Chandler 385
Houston 340
Ann Arbor 335
San Jose 315
Jacksonville 288
Boardman 273
Wilmington 248
Dallas 247
Dearborn 222
Nyköping 220
Cambridge 216
Beijing 200
Seattle 195
Helsinki 131
Santa Clara 113
Los Angeles 107
Hefei 90
Council Bluffs 87
Nanjing 87
New York 85
Hong Kong 84
Lauterbourg 78
Shanghai 66
Boston 65
Ho Chi Minh City 64
Seoul 46
The Dalles 46
Buffalo 43
Hanoi 38
Milan 38
Nanchang 38
Guangzhou 35
San Diego 32
Shenyang 32
Munich 31
São Paulo 30
Hebei 27
Jiaxing 27
Verona 26
Changsha 24
London 22
Orange 21
Tokyo 21
Toronto 20
Auburn Hills 16
Dong Ket 16
Mountain View 16
Redwood City 16
Redondo Beach 15
Rome 15
Tianjin 15
Brooklyn 14
Jinan 14
Orem 14
Tashkent 14
Brussels 13
Frankfurt am Main 13
Norwalk 13
Turku 13
Kunming 12
Manchester 12
San Francisco 12
Ningbo 11
Washington 11
Chicago 10
Columbus 9
Da Nang 9
Denver 9
Jakarta 9
Mexico City 9
Phoenix 9
Zhengzhou 9
Ansbach 8
Brasília 8
Chennai 8
Porto Alegre 8
Sassari 8
Atlanta 7
Biên Hòa 7
Guayaquil 7
Nairobi 7
Turin 7
Wuhan 7
Düsseldorf 6
Lahore 6
Rio de Janeiro 6
Taizhou 6
Warsaw 6
Caxias do Sul 5
Dhaka 5
Erbil 5
Haiphong 5
Hangzhou 5
Totale 114.053
Salva come PNG Salva come JPEG
Nome #
Proteomic investigation of whole saliva in Wilson's disease 4.329
null 3.544
Bipolar disorders and Wilson's disease 3.275
The burden of depressive and bipolar disorders in celiac disease 2.934
Coeliac disease and psychiatric comorbidity: epidemiology, pathophysiological mechanisms, quality-of-life, and gluten-free diet effects 2.755
Value of histochemical stains for copper in the diagnosis of Wilson's disease 2.744
Late onset Wilson's disease 2.597
Premature vascular deterioration in young patients affected by Wilson's disease: a pilot study 2.552
Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis? 2.444
Homogeneous magnetic resonance imaging of brain abnormalities in bipolar spectrum disorders comorbid with Wilson's disease 2.414
alpha 2 Antiplasmin and disseminated intravascular coagulation in liver cirrhosis 2.398
Mutation analysis of the ATP7B gene in a new group of Wilson's disease patients: Contribution to diagnosis. 2.360
Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease 2.348
Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena 2.305
A Top-Down proteomic study of the whole saliva of subjects affected by Wilson disease reveals qualitative and quantitative alterations of the S100A8 and S100A9 proteins 2.264
Psychiatric comorbidity in Wilson’s disease 2.259
Potential biomarker discover of the Wilson’s disease by top-down proteomic investigation of whole saliva 2.119
Quality of life and psychiatric symptoms in wilson's disease: The relevance of bipolar disorders 2.065
Histologic evolution and long-term outcome of Wilson's disease: results of a single-center experience 1.930
The relationship between copper and steatosis in Wilson's disease 1.856
TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses 1.855
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D 1.829
Fine structure of hepatic sinusoids in Wilson’s disease. A scanning electron microscopic study 1.783
Non-invasive assessment of silent liver fibrosis in patients with systemic sclerosis 1.773
A randomized controlled trial of sequential pegylated interferon-alpha and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B 1.767
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 1.736
null 1.710
Reversibility of fibrosis in Wilson disease 1.666
Uneven hepatic copper distribution in Wilson's disease 1.625
Kayser-Fleischer ring in Wilson's disease: a cohort study 1.560
Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's Disease 1.526
Brain MR spectroscopy in the evaluation of Wilson's disease: Correlation with clinical status and response to therapy 1.501
HBV and HCV infections in Wilson's disease patients: Copper overload could be protective? 1.476
Secondary RBD in a patient affected by chronic hepatic encephalopathy: a case report. 1.476
null 1.366
Dynamic 99mTc-HIDA hepatobiliary scintigraphy in vanishing bile duct syndrome 1.324
Animal models are reliably mimicking human diseases? A morphological study that compares animal with human NAFLD 1.293
Peginterferon-alpha-2a plus adefovir vs. peginterferon alpha-2a for 48 weeks in hbeag-negative chronic hepatitis B: Preliminary 24-week results of the peg for B randomized multicenter trial 1.234
Usefulness of dynamic hepatobiliary scintigraphy in Wilson's disease 1.231
Wilson’s disease with late onset 1.211
Patterns of chronic hepatitis B in Central Italy: a cross-sectional study. 1.140
Plasma prekallikrein (Fletcher factor) in hepatic cirrhosis 1.015
HFE gene mutations and Wilson's disease in Sardinia 1.009
Tolerability of Peg interferon-alpha 2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency 1.004
Syncitial giant cell hepatitis. A case report 995
Resolved Psychosis after Liver Transplantation in a Patient with Wilson's Disease 995
Massive haemosiderosis in Wilson’s disease 991
[Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy]. FT Effetto a breve termine della terapia con DL-carnitina per os ed L-carnitina e.v. nei pazienti uremici cronici in trattamento emodialitico. 985
A randomized controlled trial of pegylated interferon-alpha 2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B 967
HFE gene mutations and Wilson's disease in Sardinia 958
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study 958
Massive haemosiderosis in Wilson's disease - Reply 953
Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy 948
SEQUENTIAL PEGINTERFERON ALPHA-2A AND TELBIVUDINE OR VICE VERSA FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B: PRELIMINARY END-OF-TREATMENT RESULTS OF THE TEL-B-PEG RANDOMIZED TRIAL 926
Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease 925
Clinical features of Wilson's disease in Sardinia 850
Massive hepatic haemosiderosis in Wilson's disease 845
A randomized controlled trial of amantadine plus interferon-alpha 2a vs. interferon-alpha 2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha 2a monotherapy 841
Interferon beta-1a alone or in combination with ribavirin: A randomized trial to compare efficacy and safety in chronic hepatitis C 835
Dosage of the hepatic copper in the normal range in a patient affected by Wilson’s disease. 792
Wilson’s disease with late onset 753
Syncitial giant cell hepatitis: a new form of chronic liver disease 718
Ductular reaction and oval cell prolipheration in chronic hepatitis C. 694
Peginterferon alpha-2a (40kD) monotherapy vs peginterferon alpha-2a and ribavirin in naive patients with chronic hepatitis C: Preliminary results of the SMIEC II trial in patients with early viral clearance on peginterferon monotherapy 690
Unusual evolution from overt autoimmune hypothyroidism to hyperthyroidism after IFN-α therapy for chronic hepatitis. 690
Chronic viral hepatitis in Hiv + drug addicts 646
Enhanced response to peginterferon-alpha-2a-based triple therapy in previously non-responsive chronic hepatitis C: Final results of pretty study RID E-8970-2010 641
Comparison of MRI, EEG, EPs and ECD-SPECT in Wilson's disease 638
Epidemiologic study of hepatolenticular degeneration (Wilson's disease) in Sardinia (1902-1983) 617
Computerized cranial tomography in presymptomatic and hepatic form of Wilson's disease 609
Final results of the SMIEC trial in natve patients with hepatitis C: Double therapy (peginterferonalfa2a+ribavirin) vs peginterferon monotherapy in early viral responders and vs triple therapy (peginterferon plus ribavirin plus amantadine) in early non responders 584
[Plasma prekallikrein (Fletcher factor) in hepatic cirrhosis]. FT La precallicreina plasmatica (fattore Fletcher) nella cirrosi epatica. 572
Wilson's disease maps between the D13S169 and D13S173 loci 566
HCV transmission in family members of subjects with HCV related chronic liver disease 541
Predictive testing for Wilson's disease using tightly linked and flanking DNA markers 530
null 520
Diagnostic value of 24 hr urinary copper excretion after penicillamine challenge in the adult Wilson's disease patients. 515
Coagulazione, fibrinolisi e shunt porto-sistemico nelle epatopatie croniche 503
IS INTRAPULMONARY SHUNT IN CIRRHOTIC-PATIENTS CORRELATED WITH PORTACAVAL-SHUNT 489
HDL-cholesterol in chronic uremia during hemodialytic treatment 478
A randomized controlled trial of amantadine plus interferon alpha-2a vs interferon-alpha-2a in naive patients with chronic hepatitis C randomized based on early response to interferon alpha-2a alone. 471
Idiopathic adulthood ductopenia presenting with chronic recurrent cholestasis. A case report 465
Pseudo-porphyria cutanea tarda in patients hemodialyzed for chronic renal insufficiency. Clinical, metabolic and immunological aspect 446
Usefulness and limitations of determination of lactate dehydrogenase enzymes in the diagnosis of liver diseases 429
Transient elastography in patients with chronic autoimmune hepatitis: is a goog tool in evaluation of hepatic fibrosis? 405
The role of a double liver needle biopsy in the diagnosis of Wilson's disease. 391
Hypothalamo-pituitary-adrenal function in liver cirrhosis of viral etilogy 373
Diagnostic value of histochemical stains for copper in Wilson's disease 366
Efficacy of lamivudine in patients with antiHBe plus chronic active hepatitis B. 359
Efficacy and safety of long-term IFN therapy in active chronic hepatitis D: Six years of sustained response to the treatment. Case report. 357
ABNORMAL PULMONARY EPITHELIAL PERMEABILITY IN LIVER-CIRRHOSIS 354
Serum ALT level, phlebotomy treatment and alpha-interferon therapy in chronic hepatitis C. 288
Totale 118.064
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.823
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.800 0 615 443 495 513 825 601 319 419 514 902 1.154
2022/20238.388 993 1.192 1.086 737 831 914 320 665 385 416 485 364
2023/20247.300 491 421 320 788 762 1.091 953 480 343 536 588 527
2024/20259.186 2.045 2.139 1.148 944 599 643 817 93 211 156 184 207
2025/20266.367 242 280 581 508 302 277 618 433 2.152 461 325 188
2026/2027229 90 139 0 0 0 0 0 0 0 0 0 0
Totale 118.064